Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Visualize Index Level and price together to reveal trend strength and timing. This overview helps traders align momentum with price moves.
28,655 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
A fund just opened million in Trustmark shares signals conviction, but it isn’t a guaranteed win. This guide explains...
As Synopsys reports strong Q2 results, investors weigh AI-driven catalysts against a heavy debt load and amortization...
A quarterly filing may seem dry, but it can reveal game-changing shifts in ultra-wealthy portfolios. This article exp...
Amazon returns to the bond market to fund AI infrastructure growth as hyperscalers shift from cash to credit. Analyst...
Commercial Metals posted a blowout quarter in Q2 2026, with revenue hitting $2.132 billion and net income of $93 mill...
A new nonprofit research lab launched by five former Ethereum Foundation researchers aims to make Ethereum the settle...
META prepares for its July 29 earnings report as investors scrutinize AI-driven ad efficiency and growing monetizatio...
Rising U.S.-Iran hostilities put desalination plants in the line of fire, risking water shortages and higher costs fo...
The shift in AI spending is reshaping winners and losers. This article explains why a power-semiconductor-focused com...
Two AI hardware names—Astera Labs and Navitas Semiconductor—shine for investors through very different revenue paths....
An executive at Fresh Del Monte sold 2,622 shares. This article explains what that means for investors, how to read i...